260 related articles for article (PubMed ID: 11714886)
21. Diuretic and renal protective effects of 8-(noradamantan-3-yl)-1,3-dipropylxanthine (KW-3902), a novel adenosine A1-receptor antagonist, via pertussis toxin insensitive mechanism.
Mizumoto H; Karasawa A; Kubo K
J Pharmacol Exp Ther; 1993 Jul; 266(1):200-6. PubMed ID: 8331558
[TBL] [Abstract][Full Text] [Related]
22. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
[TBL] [Abstract][Full Text] [Related]
23. Kinin antagonist blunts the diuretic effect of furosemide in deoxycorticosterone-treated rats.
Madeddu P; Glorioso N; Pinna Parpaglia P; Demontis MP; Varoni MV; Fattaccio MC; Sabino G; Pisanu G; Patteri G; Anania V
Agents Actions Suppl; 1992; 38 ( Pt 3)():156-62. PubMed ID: 1462856
[TBL] [Abstract][Full Text] [Related]
24. Cardiorenal effects of adenosine subtype 1 (A1) receptor inhibition in an experimental model of heart failure.
Lucas DG; Hendrick JW; Sample JA; Mukherjee R; Escobar GP; Smits GJ; Crawford FA; Spinale FG
J Am Coll Surg; 2002 May; 194(5):603-9. PubMed ID: 12022600
[TBL] [Abstract][Full Text] [Related]
25. Input rate as a major determinant of furosemide pharmacodynamics: influence of fluid replacement and hypoalbuminemia.
Castañeda-Hernández G; Vergés J; Pichette V; Héroux L; Caillé G; du Souich P
Drug Metab Dispos; 2000 Mar; 28(3):323-8. PubMed ID: 10681377
[TBL] [Abstract][Full Text] [Related]
26. Furosemide renal excretion rate and the effects of the diuretic on different tubular sites are modified by endogenous dopamine in normohydrated rats.
Nowicki S; Opezzo JA; Levin G; Gonzalez D; Elias MM
J Pharmacol Exp Ther; 1995 Sep; 274(3):1348-54. PubMed ID: 7562507
[TBL] [Abstract][Full Text] [Related]
27. Supra-additive natriuretic synergism between bendroflumethiazide and furosemide in rats.
Jonassen TE; Grønbeck L; Shalmi M; Petersen JS; Andreasen F; Christensen S
J Pharmacol Exp Ther; 1995 Nov; 275(2):558-65. PubMed ID: 7473139
[TBL] [Abstract][Full Text] [Related]
28. Effects of renal papillary-medullary lesion on the antihypertensive effect of furosemide and development of salt-sensitive hypertension in Dahl-S rats.
Haugan K; Shalmi M; Petersen JS; Marcussen N; Spannow J; Christensen S
J Pharmacol Exp Ther; 1997 Mar; 280(3):1415-22. PubMed ID: 9067331
[TBL] [Abstract][Full Text] [Related]
29. Captopril-furosemide survival study in experimental heart failure.
Mougenot N; Bos R; Médiani O; Lechat P
Fundam Clin Pharmacol; 2005 Aug; 19(4):457-64. PubMed ID: 16011733
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic-independent anti-natriuretic effect of urotensin II in spontaneously hypertensive rats.
Shi Y; Cao YX; Lu N; Yao T; Zhu YC
Peptides; 2008 May; 29(5):783-94. PubMed ID: 18420307
[TBL] [Abstract][Full Text] [Related]
31. Effect of furosemide on renal function of the newborn piglet.
Noordewier B; Bailie MD; Hook JB
Pediatr Pharmacol (New York); 1980; 1(2):113-20. PubMed ID: 7346735
[TBL] [Abstract][Full Text] [Related]
32. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
33. Diuretic effects of KW-3902, a novel adenosine A1-receptor antagonist, in anesthetized dogs.
Yamagata T; Kobayashi T; Kusaka H; Karasawa A
Biol Pharm Bull; 1994 Dec; 17(12):1599-603. PubMed ID: 7735202
[TBL] [Abstract][Full Text] [Related]
34. Arterial blood pressure and renal sodium excretion in dopamine D3 receptor knockout mice.
Staudacher T; Pech B; Tappe M; Gross G; Mühlbauer B; Luippold G
Hypertens Res; 2007 Jan; 30(1):93-101. PubMed ID: 17460376
[TBL] [Abstract][Full Text] [Related]
35. Involvement of renal dopamine synthesis in the diuretic effect of furosemide in normohydrated rats.
Nowicki S; Levin G; Enero MA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1377-80. PubMed ID: 8450472
[TBL] [Abstract][Full Text] [Related]
36. Effects of chronic octreotide treatment on renal changes during cirrhosis in rats.
Jonassen TE; Christensen S; Sørensen AM; Marcussen N; Flyvbjerg A; Andreasen F; Petersen JS
Hepatology; 1999 May; 29(5):1387-95. PubMed ID: 10216120
[TBL] [Abstract][Full Text] [Related]
37. Dynamics of renal excretory function after furosemide or ethacrynic acid administration to unanaesthetized dogs after mannitol infusion or chronic renal denervation.
Girchev R; Kabakchieva E; Vrabchev N; Natcheff N; Natochin Y
Acta Physiol Hung; 1985; 65(2):137-48. PubMed ID: 3920869
[TBL] [Abstract][Full Text] [Related]
38. [The effect of using furosemide in selective adrenergic alpha 1-receptor stimulation and alpha 1-receptor blockade].
Pir'ova B; Gŭrchev R
Eksp Med Morfol; 1990; 29(1):31-6. PubMed ID: 2168831
[TBL] [Abstract][Full Text] [Related]
39. Effects of the V(2)-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats.
Hirano T; Yamamura Y; Nakamura S; Onogawa T; Mori T
J Pharmacol Exp Ther; 2000 Jan; 292(1):288-94. PubMed ID: 10604960
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular and renal characteristics, and responses to acute volume expansion of a rat model of diabetic pregnancy.
Tang D; Yu T; Khraibi AA
Life Sci; 2004 Apr; 74(23):2909-18. PubMed ID: 15050428
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
